Nuvectis Pharma (NVCT) vs Sagimet Biosciences Series A (SGMT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Nuvectis Pharma (NVCT) has outperformed Sagimet Biosciences Series A (SGMT) over the past year, gaining 232.1% versus a gain of 21.0%. Nuvectis Pharma is the larger company by market cap ($662.3 million vs $629.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NVCT | SGMT |
|---|---|---|
| Share price | $20.29 | $8.88 |
| Market cap | $662.35M | $629.67M |
| 1-day change | +1.30% | +1.37% |
| YTD return | +168.74% | +50.00% |
| 1-year return | +232.08% | +20.98% |
| EPS (TTM) | $-1.31 | $-1.27 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $29.28 | $11.45 |
| 52-week low | $5.55 | $4.50 |
| Distance from 52-week high | -30.69% | -22.44% |
| Average volume | 219.45K | 1.24M |
| Shares outstanding | 32.64M | 70.34M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NVCT has outperformed SGMT by 211.1 percentage points over the past year.
NVCT vs SGMT FAQ
Which is bigger, Nuvectis Pharma or Sagimet Biosciences Series A?
Nuvectis Pharma (NVCT) is larger, with a market capitalization of $662.35M compared with $629.67M for Sagimet Biosciences Series A (SGMT).
Which stock has performed better over the past year, NVCT or SGMT?
NVCT returned +232.08% over the past 12 months, compared with +20.98% for SGMT (price return, excluding dividends). Past performance does not predict future results.
Are Nuvectis Pharma and Sagimet Biosciences Series A in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.